The Pediatric Cancer Research Foundation (PCRF) is dedicated to identifying and investing in leading-edge research with the best hope for curing childhood cancer. Since its inception in 1982, PCRF aims to eliminate childhood cancer through research, highlighting the grave statistics that elucidate the prevalent threat of pediatric cancer globally. With over $51 million raised for cancer research and significant progress in increasing survival rates, PCRF continues its mission by funding research that promises hopeful advancements towards curing, treating, and improving the quality of life for children affected by cancer.
The PCRF focuses on accelerating cures from the laboratory to the patient's bedside through its Translational Research Grant. This grant supports new research protocols and therapies targeting improved outcomes for children and teens with high-risk cancers. It emphasizes multi-institutional cancer clinical trials or consortia that implement innovative approaches to therapy. With the possibility of funding up to $100,000 per year for multiple years, this grant aims to bring the latest and most promising life-saving treatments to children suffering from cancer, thereby offering hope and contributing to the ongoing battle against pediatric cancer.